Abstract
Background Patients with Hereditary Spastic Paraplegia (HSP) report reduced quality of life (QoL) compared to the general population. Generic QoL measures do not address disease-specific aspects such as spasticity, access to specialty HSP clinics, and bladder symptoms. We designed and validated an HSP-specific QoL scale (HSPQoL), intended for use in standard clinical settings and clinical trials.
Methods HSP-specific items were added to the RAND 36-Item Short Form Health Survey (SF-36) to form HSPQoL. Following literature review/expert input, 23 items were presented to a panel of HSP clinicians, patients, and patient representatives (n=12) using a modified Delphi process. Items were ranked for clarity and relevance (inclusion criteria: 80% consensus). Interviews with patients (n=5) assessed suitability, comprehension, clarity, and response options to additional items. Patients completed the HSPQoL and EQ5D-5L for evaluation of construct validity (correlation, exploratory factor analysis) and test-retest reliability.
Results Following the modified Delphi process, 21/23 items met the inclusion criteria. Based on cognitive interview results, items were modified (n=4), removed (n=7), or added (n=3). Sixty-one participants completed the HSPQoL and EQ5D-5L. The HSPQoL was repeated with 19 patients: 15/17 additional items moderately to strongly correlated with pre-existing SF-36 subscores (Spearman correlation 0.319-0.771, p<0.05). Exploratory factor analyses showed high percentage of variance in the first component (>45%). HSPQoL demonstrated good internal consistency (Cronbach alpha 0.94), test-retest reliability (ICC 0.957), and convergent validity with EQ5D-5L (r=0.725).
Conclusions Demonstrated validity and reliability of the HSPQoL confirms consideration of its use for assessing specific QoL in individuals with HSP.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Sue Faye Siow is the recipient of a National Health and Medical Research Council Postgraduate Scholarship and Australian and New Zealand Association of Neurologists Education and Research Foundation Scholarship. No other funding was received for conducting this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by Northern Sydney Local Health District Human Research Ethics Committee, ethics approval number 2019/ETH13187.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Conflict of interest statement The authors have no competing interests to declare that are relevant to the content of this article. The authors declare they have no financial interests.
Funding Sue Faye Siow is the recipient of a National Health and Medical Research Council Postgraduate Scholarship and Australian and New Zealand Association of Neurologists Education and Research Foundation Scholarship. No other funding was received for conducting this study.
Ethics approval This study was approved by Northern Sydney Local Health District Human Research Ethics Committee, ethics approval number 2019/ETH13187.
Data availability statement The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
Data Availability
All data produced in the present study are available upon reasonable request to the authors